Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology-Reference-Cited by-同舟云学术

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology

Published:2022-04 Issue:4 Volume:54 Page:428-439
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Bonovas Stefanos^ORCID,Pansieri Claudia,Piovani Daniele,Macaluso Fabio Salvatore,Orlando Ambrogio,Festa Stefano,Papi Claudio,Pugliese Daniela,Armuzzi Alessandro

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference49 articles.

1. Ulcerative colitis;Ungaro;Lancet,2017

2. Ulcerative colitis as a progressive disease: the forgotten evidence;Torres;Inflamm Bowel Dis,2012

3. Ulcerative colitis;Kobayashi;Nat Rev Dis Primers,2020

4. Inflammatory bowel disease: clinical aspects and established and evolving therapies;Baumgart;Lancet,2007

5. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses;Piovani;Gastroenterology,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus;Autoimmunity Reviews;2024-05

2. Economic evaluation of two therapeutic sequences in the first-line treatment of moderate to severe active ulcerative rectocolitis in Italy;AboutOpen;2024-03-02

3. Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”;Digestive and Liver Disease;2024-02

4. Racial Disparities in Infliximab Efficacy for Ulcerative Colitis: Evidence Synthesis and Effect Modification Assessment;Journal of Clinical Medicine;2024-01-05

5. Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study;Digestive and Liver Disease;2024-01